AI Summary & Key Takeaways
AI InsightWe found that theTurkish translation of BMQ is a valid and reliable tool for assessing medicine-related beliefs in patients with asthma and COPD.
📌 3 Key Takeaways
Özet
OBJECTIVES: Inadequate adaptation to long-term treatment of chronic illnesses is the most common reason for the inability to obtain thebenefits medications can provide. Treatment compliance is influenced by several factors. Beliefs about Medicines Questionnaire (BMQ)developed by Horne et al. in 1999 to evaluate the cognitive representation of medicines have many validation studies, which resulted ingood psychometric properties. The aim of the present study was to evaluate the reliability and validity of the BMQ Turkish translation inpatients with asthma and chronic obstructive pulmonary disease (COPD).MATERIAL AND METHODS: Fifty asthma and 50 COPD patients participated in this methodological study. The scale was adapted toTurkish through translation, comparison with other language versions, back translation, and a pre-test. The structural validity was as-sessed using factor analysis.RESULTS: Similar to the original scale, factor analysis confirmed that BMQ had a four-factor structure that accounts for 58.23% of thetotal variance. The BMQ showed an acceptable internal consistency (Cronbach's alpha coefficient: specific-necessity, 0.832: specific-concerns, 0.722; general-harm, 0.792; and general-overuse, 0.682). The factor analysis revealed the same patterns for all questionsbetween the Turkish and original scales.CONCLUSION: The psychometric properties of the BMQ were consistent with those reported in the original study. We found that theTurkish translation of BMQ is a valid and reliable tool for assessing medicine-related beliefs in patients with asthma and COPD.